Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody
- PMID: 37045780
- DOI: 10.1507/endocrj.EJ22-0637
Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody
Abstract
Lymphocytic hypophysitis (LYH) is a rare chronic inflammatory disease characterized by lymphocytic infiltration of the anterior or posterior pituitary gland and hypothalamus. LYH is subdivided into lymphocytic adenohypophysitis (LAH), lymphocytic infundibulo-neurohypophysitis (LINH), and lymphocytic panhypophysitis (LPH) depending on the primary site. Most cases occur in adults, with few cases reported in children, and it is especially important to distinguish LYH from suprasellar malignancies, such as germ cell tumors and other neoplastic diseases. Although a biopsy is necessary for definitive diagnosis, it is desirable to be able to diagnose the disease without biopsy if possible, especially in children, because of the surgical invasiveness of the procedure. Recently, serum anti-rabphilin-3A antibodies have attracted attention as diagnostic markers for LYH, especially in LINH, but there are only a few reports on pediatric patients. In the present study, we experienced two children with LPH and LAH, respectively, who tested positive for anti-rabphilin-3A antibodies. This is the first report of children with LYH other than LINH positive for anti-rabphilin-3A antibodies, and anti-rabphilin-3A antibodies may be a useful non-invasive diagnostic marker not only for LINH but also for LYH in general. We also discuss the sensitivity and specificity of anti-rabphilin-3A antibody testing in cases where histological diagnosis has been made.
Keywords: Anti-rabphilin-3A antibody; Lymphocytic hypophysitis; Pediatrics.
Similar articles
-
Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis.J Pathol. 2018 Apr;244(4):469-478. doi: 10.1002/path.5046. Epub 2018 Mar 9. J Pathol. 2018. PMID: 29377134
-
Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.J Clin Endocrinol Metab. 2015 Jul;100(7):E946-54. doi: 10.1210/jc.2014-4209. Epub 2015 Apr 28. J Clin Endocrinol Metab. 2015. PMID: 25919460 Free PMC article.
-
A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature.Endocr J. 2024 Dec 2;71(12):1165-1173. doi: 10.1507/endocrj.EJ24-0093. Epub 2024 Aug 27. Endocr J. 2024. PMID: 39198191 Free PMC article. Review.
-
Variant of lymphocytic infundibulo-neurohypophysitis presenting with unique clinical and radiological features.Tokai J Exp Clin Med. 2012 Dec 20;37(4):126-32. Tokai J Exp Clin Med. 2012. PMID: 23238905
-
Anti-pituitary antibodies as a marker of autoimmunity in pituitary glands.Endocr J. 2020 Nov 28;67(11):1077-1083. doi: 10.1507/endocrj.EJ20-0436. Epub 2020 Oct 14. Endocr J. 2020. PMID: 33055452 Review.
Cited by
-
Diagnosis of Lymphocytic Infundibuloneurohypophysitis After Positive Anti-rabphilin-3A Antibody Test in an 8-year-old Boy with Early-onset Central Diabetes Insipidus.J Clin Res Pediatr Endocrinol. 2025 Aug 22;17(3):332-336. doi: 10.4274/jcrpe.galenos.2023.2023-5-7. Epub 2023 Sep 25. J Clin Res Pediatr Endocrinol. 2025. PMID: 37743662 Free PMC article.
-
A 4-year-old Boy Positive for Anti-rabphilin-3A Antibody and Diagnosed With Lymphocytic Infundibuloneurohypophysitis.JCEM Case Rep. 2024 Dec 26;3(1):luae214. doi: 10.1210/jcemcr/luae214. eCollection 2025 Jan. JCEM Case Rep. 2024. PMID: 39726668 Free PMC article.